抗苗勒管激素在性腺相关疾病中的应用被引量：4

下载PDF

导出

摘要抗苗勒管激素(AMH)是评价卵巢功能的敏感指标,也是许多疾病诊断中重要的辅助检查指标。AMH对多囊卵巢综合征、子宫内膜异位症的诊疗过程及治疗后卵巢功能评价、性腺相关恶性肿瘤的诊断及放化疗及术后恢复情况也具有较大意义,并有望成为新型靶向药物推动疾病诊疗的发展。性腺发育异常的患儿通过AMH监测能够达到及早发现并治疗疾病,为患者评估预后提供有效参考。

作者何艺磊李蓉乔杰

机构地区北京大学第三医院

出处《实用妇产科杂志》 CAS CSCD 北大核心 2017年第11期822-826,共5页 Journal of Practical Obstetrics and Gynecology

关键词抗苗勒管激素多囊卵巢综合征子宫内膜异位症恶性肿瘤性腺发育异常卵巢损伤

分类号 R711.7 [医药卫生—妇产科学]

引文网络
相关文献

参考文献1

1杨诗源,阮洁,黄薇,谭婧,张向卉,冯雪,刘冬,傅璟,周璐,周敏.血清抗苗勒管激素水平在基于2012年中国多囊卵巢综合征诊断标准患者中的初步研究[J].中华妇产科杂志,2015,50(11):819-824. 被引量：34

二级参考文献20

1Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest[J]. J C|in Eudocrinol Metab, 2003, 88(12): 5957-5962.
2Sahmay S, Atakul N, Aydogan B, et aL Elevated serum levels of anti-Mtillerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome[J]. Acta Obstet Gynecol Seand, 2013, 92(12):1369-1374.
3Ktininger A, Koch L, Edimiris P, et al. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian svndromeHl. Arch Gvnecol Obstet. 2014, 290(5):1023-1030.
4Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women[J]. J Clin Endocrin Metab, 1961,21:1440-1447.
5Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of novel system[J]. Int J Dermatol, 1997, 36(6):416-418.
6Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women[J]. Hum Reprod Update, 2014, 20(3):370-385.
7Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polyeystic ovaries[J]. Hum Reprod, 2011, 26(11):3123-3129.
8Homburg R, Ray A, Bhide P, et al. The relationship of sermn anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study[J]. Hum Reprod, 2013, 28(4): 1077-1083.
9Lauritsen MP, Bentzen JG, Pinborg A, et al. The prevalence of polycystie ovary syndrome in a normal populationaccording to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone[J]. Hum Reprod, 2014, 29 (4):791-801.
10Skatba P, Cygal A, Madej P, et al. Is the plasma anti-Mtillerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?[J]. Eur J Obstet Gynecol Reprod Biol, 2011,158(2):254-259.